BD Respiratory Viral Panel for BD MAX™ System - HSA Registration DE0510386
Access comprehensive regulatory information for BD Respiratory Viral Panel for BD MAX™ System in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0510386 and owned by Becton, Dickinson and Company. The device was registered on February 25, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
BD Respiratory Viral Panel for BD MAX™ System is an automated multiplexed real-time RT-PCR test intended for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and/or respiratory syncytial virus (RSV) in nasopharyngeal and anterior nasal swabs collected from individuals suspected of respiratory viral infection consistent with COVID-19, flu, or respiratory syncytial virus related symptoms by a healthcare provider. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza, and respiratory syncytial virus can be similar.